Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica Closes Financing Round Led By Reed Elsevier

NEW YORK, Nov. 8 (GenomeWeb News) - Inpharmatica said today that it has completed a £13.9 million ($25.8 million) round of financing.

 

According to Inpharmatica, the financing will be used to further develop the company's in-house and collaborative drug discovery business, and to boost licensing activities for its PharmaCarta drug discovery informatics platform. According to an Inpharmatica spokesman, the platform generates close to $10 million a year in licensing revenues.

 

Inpharmatica said that the financing was led by Reed Elsevier ventures, the venture arm of publisher Reed Elsevier, which invested £5 million in the round. The companies already have a relationship, with Elsevier subsidiary MDL Information Systems having signed on in February as a non-exclusive distributor of Inpharmatica's Biopendium proteome annotation database.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.